IRF5 and ovarian carcinoma: Coexpression of IRF5 and IKKβ (a kinase that phosphorylates and activates IRF5) mediates TAM polarization toward the M1 phenotype, suppressing tumor development in model systems of advanced-stage ovarian cancer, metastatic melanoma, and glioblastoma [294].